Dyspepsia, Peptic Ulcer Disease, and Esophageal Reflux Disease

Overview

Journal West J Med

Specialty General Medicine

Date 2002 Mar 19

PMID 11897730

Citations 7

Authors

Mark D Schwartz

Affiliations

Soon will be listed here.

Citing Articles

Diagnostic utility of alarm features in predicting malignancy in patients with dyspeptic symptoms.

Shetty A, Balaraju G, Shetty S, Pai C Indian J Gastroenterol. 2021; 40(2):183-188.

PMID: 33830441 PMC: 8187202. DOI: 10.1007/s12664-021-01155-x.

Anti-, Anti-Inflammatory, Cytotoxic, and Antioxidant Activities of Mace Extracts from .

Suthisamphat N, Dechayont B, Phuaklee P, Prajuabjinda O, Vilaichone R, Itharat A Evid Based Complement Alternat Med. 2020; 2020:7576818.

PMID: 32308716 PMC: 7146089. DOI: 10.1155/2020/7576818.

Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.

Iessi E, Logozzi M, Mizzoni D, Di Raimo R, Supuran C, Fais S Metabolites. 2018; 8(1).

PMID: 29295495 PMC: 5875992. DOI: 10.3390/metabo8010002.

Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses.

Smith I, Schmidt R, Halm E, Mansi I Clin Drug Investig. 2017; 38(2):135-146.

PMID: 29081029 DOI: 10.1007/s40261-017-0589-x.

Insights into gastric neuroendocrine tumors burden.

Thomaz Araujo T, Barra W, Khayat A, Assumpcao P Chin J Cancer Res. 2017; 29(2):137-143.

PMID: 28536492 PMC: 5422415. DOI: 10.21147/j.issn.1000-9604.2017.02.06.

References

Schappert S . Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 2000; (143):i-iv, 1-39. View

Maton P . Omeprazole. N Engl J Med. 1991; 324(14):965-75. DOI: 10.1056/NEJM199104043241406. View

Marton K, Sox Jr H, Wasson J, DUISENBERG C . The clinical value of the upper gastrointestinal tract roentgenogram series. Arch Intern Med. 1980; 140(2):191-5. View

Graham D, Lew G, Evans D, Evans Jr D, KLEIN P . Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991; 115(4):266-9. DOI: 10.7326/0003-4819-115-4-266. View

Talley N, Zinsmeister A, Schleck C, Melton 3rd L . Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992; 102(4 Pt 1):1259-68. View

Howden C, Hunt R . Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol. 1998; 93(12):2330-8. DOI: 10.1111/j.1572-0241.1998.00684.x. View

van Pinxteren B, Numans M, Bonis P, Lau J . Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2000; (2):CD002095. DOI: 10.1002/14651858.CD002095. View

Veldhuyzen van Zanten S, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M . An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ. 2000; 162(12 Suppl):S3-23. PMC: 1232536. View

Bayerdorffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S . Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995; 345(8965):1591-4. DOI: 10.1016/s0140-6736(95)90113-2. View

10.

Dooley C, Larson A, Stace N, Renner I, Valenzuela J, ELIASOPH J . Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study. Ann Intern Med. 1984; 101(4):538-45. DOI: 10.7326/0003-4819-101-4-538. View

11.

Bardhan K, Muller-Lissner S, Bigard M, Bianchi Porro G, Ponce J, Hosie J . Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ. 1999; 318(7182):502-7. PMC: 27748. DOI: 10.1136/bmj.318.7182.502. View

12.

Cave D, Hoffman J . Management of Helicobacter pylori infection in ulcer disease. Hosp Pract (1995). 1996; 31(1):63-4, 67-9, 73-5. View

13.

Klauser A, Schindlbeck N, Muller-Lissner S . Symptoms in gastro-oesophageal reflux disease. Lancet. 1990; 335(8683):205-8. DOI: 10.1016/0140-6736(90)90287-f. View

14.

Soll A . Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA. 1996; 275(8):622-9. DOI: 10.1001/jama.275.8.622. View

15.

DeVault K, Castell D . Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med. 1995; 155(20):2165-73. View

16.

Camilleri M . Nonulcer dyspepsia: a look into the future. Mayo Clin Proc. 1996; 71(6):614-22. DOI: 10.4065/71.6.614. View

17.

Schindlbeck N, Klauser A, Voderholzer W, Muller-Lissner S . Empiric therapy for gastroesophageal reflux disease. Arch Intern Med. 1995; 155(16):1808-12. View

18.

Hentschel E, Brandstatter G, Dragosics B, Hirschl A, Nemec H, Schutze K . Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993; 328(5):308-12. DOI: 10.1056/NEJM199302043280503. View

19.

Walsh J, PETERSON W . The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1995; 333(15):984-91. DOI: 10.1056/NEJM199510123331508. View

20.

Bytzer P, Hansen J, Schaffalitzky de Muckadell O . Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994; 343(8901):811-6. DOI: 10.1016/s0140-6736(94)92023-0. View